Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alcoholism

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    December 2018
  1. WONG VWS, Adams LA
    Fibroblast growth factor 21 for non-alcoholic steatohepatitis.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)32165.
    PubMed     Text format    


  2. SANYAL A, Charles ED, Neuschwander-Tetri BA, Loomba R, et al
    Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.
    Lancet. 2018 Dec 13. pii: S0140-6736(18)31785.
    PubMed     Text format     Abstract available


  3. HAGHPANAHAN H, Lewsey J, Mackay DF, McIntosh E, et al
    An evaluation of the effects of lowering blood alcohol concentration limits for drivers on the rates of road traffic accidents and alcohol consumption: a natural experiment.
    Lancet. 2018 Dec 12. pii: S0140-6736(18)32850.
    PubMed     Text format     Abstract available


    November 2018
  4. THOMPSON W
    Risk thresholds for alcohol consumption.
    Lancet. 2018;392:2167.
    PubMed     Text format    


  5. WOOD AM, Kaptoge S, Paige E, Di Angelantonio E, et al
    Risk thresholds for alcohol consumption - Authors' reply.
    Lancet. 2018;392:2167-2168.
    PubMed     Text format    


  6. SCHERNHAMMER E
    Risk thresholds for alcohol consumption.
    Lancet. 2018;392:2166-2167.
    PubMed     Text format    


  7. ASTRUP A, Costanzo S, de Gaetano G
    Risk thresholds for alcohol consumption.
    Lancet. 2018;392:2165-2166.
    PubMed     Text format    


    October 2018
  8. LEWIS SL
    Drinkaware: unequivocally committed to reducing alcohol harm.
    Lancet. 2018;392:1517-1518.
    PubMed     Text format    


    August 2018
  9. BURTON R, Sheron N
    No level of alcohol consumption improves health.
    Lancet. 2018 Aug 23. pii: S0140-6736(18)31571.
    PubMed     Text format    


    April 2018
  10. WOOD AM, Kaptoge S, Butterworth AS, Willeit P, et al
    Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.
    Lancet. 2018;391:1513-1523.
    PubMed     Text format     Abstract available


    March 2018
  11. HARRISON SA, Rinella ME, Abdelmalek MF, Trotter JF, et al
    NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2018 Mar 5. pii: S0140-6736(18)30474.
    PubMed     Text format     Abstract available


    November 2017
  12. WILLIAMS R, Alexander G, Armstrong I, Baker A, et al
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.
    PubMed     Text format     Abstract available


    January 2017
  13. BARNETT R
    Alcohol use disorders.
    Lancet. 2017;389:25.
    PubMed     Text format    


    December 2016
  14. NADKARNI A, Weobong B, Weiss HA, McCambridge J, et al
    Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial.
    Lancet. 2016 Dec 14. pii: S0140-6736(16)31590.
    PubMed     Text format     Abstract available


  15. AGABIO R
    Non-specialist health workers to treat excessive alcohol consumption and depression.
    Lancet. 2016 Dec 14. pii: S0140-6736(16)32566.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alcoholism is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: